.Net Journal Pricing Study 
Xconomy
AUGUST 19, 2016
And once in a while, a defender uses his or her face, inadvertently, to block a ball spiked over the net. Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data. Talk about sacrifice.
Xconomy
NOVEMBER 4, 2016
The Mayo Clinic cardiologist behind the report published a study earlier this year about long QT misdiagnosis leading to improper defibrillator implants. Its owner Pfizer (NYSE: PFE ) shelved it this week , citing poor Phase 3 data and pricing pressures on the two approved PCSK9 drugs. Pfizer also reported worse-than-expected earnings.
Expert insights. Personalized for you.
40 
Let's personalize your content